Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Trinity › NPI 1891741849
Hospital

New Port Richey Hospital INC

New Port Richey Hospital INC was paid $13.57M by Medicaid between Jan 2018 and Dec 2024, across 167 billing codes. Its largest line is 99283, emergency room visit (moderate) — 31% of everything it billed.

33Billing provider infoNEW PORT RICHEY HOSPITAL INC
TRINITY, FL 34655
33aNPI1891741849assigned 05/25/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$13.57M
24GClaims609,912
24DCodes billed167
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Florida

Rank by total paid#35 of 163
Median peer was paid$4.77M
This provider vs. median2.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201837,871$340K
2019123,555$1.62M
202093,672$1.39M
2021121,229$2.98M
2022118,609$3.56M
202372,044$2.25M
2024incomplete42,932$1.43M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 31% 57,544 53,003 $4.25M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 13% 40,938 35,458 $1.77M
80053 Comprehensive metabolic panel 9.1% 37,716 31,815 $1.23M
74177 Computed tomography, abdomen and pelvis; with contrast material 8.2% 6,609 6,002 $1.11M
70450 Computed tomography, head or brain; without contrast material 5.9% 6,627 5,454 $803K
99282 Emergency department visit for the evaluation and management, low to moderate severity 4.8% 9,996 9,361 $649K
99281 Emergency department visit for the evaluation and management, self-limited or minor 3.5% 5,344 4,811 $473K
96361 Intravenous infusion, hydration; each additional hour 2.3% 2,843 2,435 $318K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.1% 6,113 5,184 $283K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.6% 1,950 1,712 $215K
71275 Computed tomographic angiography, chest, with contrast material 1.4% 1,241 1,102 $185K
87070 1.4% 8,872 8,333 $184K
155 more codes
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 11,448 $106K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,485 $105K
81001 <1% 19,190 $102K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 15,346 $89K
80048 Basic metabolic panel (calcium, ionized) <1% 5,638 $87K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 913 $78K
87040 <1% 2,811 $74K
G0378 Hospital observation service, per hour <1% 5,238 $63K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 3,695 $61K
81003 <1% 9,227 $60K
71045 Radiologic examination, chest; single view <1% 15,168 $59K
71046 Radiologic examination, chest; 2 views <1% 5,660 $58K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 2,035 $56K
A9270 Non-covered item or service <1% 12,699 $53K
76818 <1% 878 $48K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 3,013 $47K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 1,851 $46K
87086 Culture, bacterial; quantitative colony count, urine <1% 4,321 $44K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,457 $42K
72125 Computed tomography, cervical spine; without contrast material <1% 2,131 $40K
84703 <1% 11,298 $39K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 5,563 $38K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 997 $29K
12001 <1% 536 $27K
84702 <1% 3,435 $24K
85027 <1% 44,330 $24K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 22,066 $23K
12011 <1% 386 $22K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 787 $22K
73630 <1% 1,568 $21K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 407 $21K
73130 <1% 1,393 $20K
73610 <1% 1,362 $19K
76819 Fetal biophysical profile; without non-stress testing <1% 507 $18K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,305 $18K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 10,095 $18K
73030 <1% 1,020 $16K
81025 <1% 3,961 $16K
J7030 Infusion, normal saline solution , 1000 cc <1% 17,993 $16K
74018 <1% 797 $16K
73562 <1% 1,440 $15K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 1,629 $15K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 15,869 $15K
87210 <1% 1,067 $14K
73110 <1% 942 $14K
72110 <1% 511 $13K
86850 <1% 1,952 $13K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 587 $12K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,578 $11K
S0028 Injection, famotidine, 20 mg <1% 1,972 $8K
87807 <1% 2,492 $8K
84484 <1% 12,606 $8K
10060 <1% 108 $8K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 412 $8K
93971 <1% 717 $7K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 9,587 $7K
85610 <1% 6,654 $6K
73140 <1% 271 $6K
84112 <1% 111 $6K
70491 <1% 24 $6K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,106 $6K
76010 <1% 272 $6K
74022 <1% 93 $6K
85730 <1% 6,316 $5K
84156 <1% 1,148 $5K
86900 <1% 3,112 $5K
96375 Therapeutic injection; each additional sequential IV push <1% 7,517 $5K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 85 $5K
87186 <1% 2,232 $4K
83880 <1% 2,733 $4K
59025 Fetal non-stress test <1% 88 $4K
76830 Ultrasound, transvaginal <1% 351 $4K
01967 Neuraxial labor analgesia/anesthesia for planned vaginal delivery <1% 33 $4K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 7,256 $4K
70486 <1% 144 $4K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 2,154 $3K
86901 <1% 3,117 $3K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 5,588 $3K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 957 $3K
C1769 Guide wire <1% 216 $3K
93970 <1% 32 $3K
J7120 Ringers lactate infusion, up to 1000 cc <1% 2,594 $3K
J1815 Injection, insulin, per 5 units <1% 707 $3K
85379 <1% 1,811 $3K
72131 <1% 31 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,753 $2K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 510 $2K
74019 <1% 25 $2K
84443 Thyroid stimulating hormone (TSH) <1% 1,541 $2K
73090 <1% 135 $2K
83690 <1% 10,598 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 8,325 $2K
87205 <1% 501 $2K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,584 $2K
83735 <1% 4,618 $2K
82570 <1% 998 $2K
80143 <1% 810 $2K
96376 <1% 1,770 $1K
73502 <1% 76 $1K
80076 <1% 902 $1K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 451 $1K
83605 <1% 2,080 $1K
12002 <1% 12 $923.55
73080 <1% 90 $846.95
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,913 $842.12
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,843 $815.45
J8540 Dexamethasone, oral, 0.25 mg <1% 600 $700.64
73590 <1% 45 $693.04
80061 Lipid panel <1% 456 $486.10
84550 <1% 1,145 $485.14
90715 <1% 390 $485.07
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 617 $474.49
97162 <1% 12 $441.03
71101 <1% 12 $354.04
84439 <1% 61 $315.69
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 2,341 $293.52
84145 <1% 109 $285.35
J1644 Injection, heparin sodium, per 1000 units <1% 271 $262.62
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 13 $225.46
J2270 Injection, morphine sulfate, up to 10 mg <1% 4,101 $223.44
82550 <1% 144 $199.03
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 18 $193.55
81050 <1% 194 $183.65
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 57 $143.13
36415 Collection of venous blood by venipuncture <1% 507 $112.57
J7050 Infusion, normal saline solution, 250 cc <1% 768 $109.87
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 58 $95.00
29125 <1% 49 $79.12
88307 <1% 14 $59.58
J1170 Injection, hydromorphone, up to 4 mg <1% 943 $58.27
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 164 $53.77
J3490 Unclassified drugs <1% 16 $33.69
G1003 Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program <1% 414 $20.27
J2060 Injection, lorazepam, 2 mg <1% 838 $11.24
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 158 $6.98
83036 Hemoglobin; glycosylated (A1C) <1% 57 $5.62
82248 <1% 71 $2.96
84100 <1% 46 $2.94
87075 0% 39 $0.00
72070 0% 14 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 56 $0.00
C1758 Catheter, ureteral 0% 30 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 36 $0.00
87147 0% 115 $0.00
86308 0% 70 $0.00
86140 0% 30 $0.00
85651 0% 15 $0.00
J2704 Injection, propofol, 10 mg 0% 106 $0.00
S0020 Injection, bupivicaine hydrochloride, 30 ml 0% 19 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 44 $0.00
J0690 Injection, cefazolin sodium, 500 mg 0% 19 $0.00
82150 0% 12 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 20 $0.00
72170 0% 19 $0.00
88342 0% 19 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWYERS, MICHAEL (CFO)